Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: csizmarik a. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509931 Free PMC article. Review.
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Csizmarik A, Ristl R, Puhr M, Hoffmann MJ, Niedworok C, Hadaschik B, Maj-Hes A, Shariat SF, Kramer G. Szarvas T, et al. Among authors: csizmarik a. BJU Int. 2018 Oct;122(4):695-704. doi: 10.1111/bju.14415. Epub 2018 Jun 20. BJU Int. 2018. PMID: 29802777
High-soluble CGA levels are associated with poor survival in bladder cancer.
Szarvas T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, Nyirády P, Oláh C, Széll T, Csizmarik A, Hadaschik B, Reis H. Szarvas T, et al. Among authors: csizmarik a. Endocr Connect. 2019 May 1;8(5):625-633. doi: 10.1530/EC-19-0068. Endocr Connect. 2019. PMID: 30999279 Free PMC article.
Prevalence of APC and PTEN Alterations in Urachal Cancer.
Nagy N, Reis H, Hadaschik B, Niedworok C, Módos O, Szendrői A, Bíró K, Hager T, Herold T, Ablat J, Black PC, Okon K, Tolkach Y, Csizmarik A, Oláh C, Keresztes D, Bremmer F, Gaisa NT, Kriegsmann J, Kovalszky I, Kiss A, Tímár J, Szász MA, Rink M, Fisch M, Nyirády P, Szarvas T. Nagy N, et al. Among authors: csizmarik a. Pathol Oncol Res. 2020 Oct;26(4):2773-2781. doi: 10.1007/s12253-020-00872-6. Epub 2020 Aug 4. Pathol Oncol Res. 2020. PMID: 32754865 Free PMC article.
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy.
Szarvas T, Csizmarik A, Váradi M, Fazekas T, Hüttl A, Nyirády P, Hadaschik B, Grünwald V, Tschirdewahn S, Shariat SF, Sevcenco S, Maj-Hes A, Kramer G. Szarvas T, et al. Among authors: csizmarik a. Urol Oncol. 2021 May;39(5):296.e11-296.e19. doi: 10.1016/j.urolonc.2020.09.005. Epub 2020 Oct 9. Urol Oncol. 2021. PMID: 33046366 Free article.
26 results